Results 121 to 130 of about 9,065 (221)

Building OLAP Catalog [PDF]

The Oracle OLAP option of Oracle Database 10g Enterprise Edition provides advanced analytic features to help us to summarize, analyze and calculate data faster than standard SQL.
Mihaela MUNTEAN
core  

Olap

, 2010
Presentación que explica todo lo relacionado con OLAP, su aplicación y funcionamiento y desde luego su importancia.It is a process that focuses on data analysis and exploration and data tools access data for monitoring purposes.
Forero, Felipe
core  

Combination olaparib and cyclophosphamide cancer therapy exacerbates ovarian reserve depletion in mice with conditional loss of <i>Brca1</i> in oocytes. [PDF]

Front Endocrinol (Lausanne)
Cao Y, Jalil ZA, Mu X, Stringer JM, Zerafa N, Winship AL, Hutt KJ.   +6 more
europepmc   +1 more source

Cannabidiol potentiates olaparib-induced cytotoxicity through cell cycle arrest and DNA damage modulation in breast cancer cells. [PDF]

Mol Cell Biochem
Deniz C, Yüksel B, Cebeci E, Şahin F.
europepmc   +1 more source

Defective DNA Damage Response Is a Targetable Therapeutic Vulnerability in ESR1-Mutant Breast Cancer. [PDF]

Cancer Res
Herzog SK, Stevens JH, Gu G, Grimm SL, Cardoza K, Hawkins AGM, Lin H, Ramos D, Beyer AR, Edwards DG, Dustin D, Yang HJ, Liang N, Khan AF, Bawa-Khalfe T, McGrail DJ, Lin SY, Coarfa C, Fuqua SAW.   +18 more
europepmc   +1 more source

Matching-adjusted indirect comparisons of PARP inhibitor combinations in metastatic castration-resistant prostate cancer across key populations. [PDF]

Oncologist
Castro E, Wang D, Paganelli S, Haltner A, Su N, Kirker M, Chang J, Samjoo IA.   +7 more
europepmc   +1 more source

Oxidized mC modulates synthetic lethality to PARP inhibitors for the treatment of leukemia. [PDF]

Cell Rep, 2023
Brabson JP, Leesang T, Yap YS, Wang J, Lam MQ, Fang B, Dolgalev I, Barbieri DA, Strippoli V, Bañuelos CP, Mohammad S, Lyon P, Chaudhry S, Donich D, Swirski A, Roberts E, Diaz I, Karl D, Dos Santos HG, Shiekhattar R, Neel BG, Nimer SD, Verdun RE, Bilbao D, Figueroa ME, Cimmino L.   +25 more
europepmc   +1 more source

Evaluating the biological characteristics of targeted ZIF-8-encapsulated individual and combined drug systems for enhanced <i>in vivo</i> toxicity mitigation using folic acid ligands. [PDF]

RSC Adv
Sadeq NS, Masarudin MJ, Abdul Rahman MB, Chia SL, Ahmad S, Ahmad H.   +5 more
europepmc   +1 more source

Essential Data Elements for Laboratory Test Interoperability: An Expert Consensus-Based Framework. [PDF]

Ann Lab Med
Kim HN, Kim MS, Kim S, Park K, Cho EJ, Ryu H, Oh Y, Yu S, Rim JH, Kim SM, Park G, Lee J, Lee HS, Choi HW, Lee YK, Shin JH, Lee SG, Lee YK, Ahn JY, Chun S, Park J, Kim JY, Kim HH, Kwon A, Lee K, Yun YM, An D, Shin S, Ji H, Standardization Management Committee of the Laboratory Medicine Foundation, Clinical Practice Guidelines Committee of the Korean Society for Laboratory Medicine.   +30 more
europepmc   +1 more source

Functional and omics-based rationale for the induction of BRCAness by androgen receptor pathway inhibitors to sensitize prostate cancer to PARP inhibition, regardless of HRR status. [PDF]

Br J Cancer
Elsesy ME, Moustafa A, Oh-Hohenhorst SJ, Müller C, Alawi M, Mair T, Siebels B, Hu Z, Hahn J, Burdak-Rothkamm S, Tilki D, Schlüter H, Petersen C, Maurer T, von Amsberg G, Bokemeyer C, Rothkamm K, Mansour WY.   +17 more
europepmc   +1 more source